COMPANY

Milvue
Healthcare technology company based in Paris, France
Founded 2018Paris, France
Product: TechCare Alert Company: Milvue
Springer Nature Link, 2025
To determine the performance of a commercially available AI tool for fracture detection when used in children with osteogenesis imperfecta (OI).
All appendicular and pelvic radiographs from an OI clinic at a single centre from 48 patients were included. Seven radiologists evaluated anonymised images in two rounds, first without, then with AI assistance. Differences in diagnostic accuracy between the rounds were analysed.
48 patients (mean 12 years) provided 336 images, containing 206 fractures established by consensus opinion of two radiologists. AI produced a per-examination accuracy of 74.8% [95% CI: 65.4%, 82.7%], compared to average radiologist performance at 83.4% [95% CI: 75.2%, 89.8%]. Radiologists using AI assistance improved average radiologist accuracy per examination to 90.7% [95% CI: 83.5%, 95.4%]. AI gave more false negatives than radiologists, with 80 missed fractures versus 41, respectively. Radiologists were more likely (74.6%) to alter their original decision to agree with AI at the per-image level, 82.8% of which led to a correct result, 64.0% of which were changing from a false positive to a true negative.
Despite inferior standalone performance, AI assistance can still improve radiologist fracture detection in a rare disease paediatric population. Radiologists using AI typically led to more accurate diagnostic outcomes through reduced false positives. Future studies focusing on the real-world application of AI tools in a larger population of children with bone fragility disorders will help better evaluate whether these improvements in accuracy translate into improved patient outcomes.